Press release – Friday, December 8, 2017
For immediate release
SUNNYVALE, CA, December 8, 2017 –
Apostle Inc is pleased to announce the signing of an agreement with Filgen Inc to supply and distribute
Apostle’s technological products exclusively in Japan.
"Filgen is a well-respected and strong distributor in life science in Japan. " said Bo Zhang, PhD, VP of Chemistry of Apostle. “As a biotechnology innovator in the Silicon Valley, Apostle is pleased to collaborate with Filgen and is confident that this business relationship will bring critical advancements for the liquid biopsy activities in Japan.”
"We are pleased to have the opportunity of becoming a sales partner of Apostle Inc,” said Mr. Manabu Harada, General Manager of Bioscience Department of Filgen, “Since we work in this field on a daily basis, we have a chance to sense the needs of our customers. Liquid biopsy is becoming a big thing in Japan. We believe that the outstanding products of Apostle would fill an important need by improving the performance of liquid biopsy with its cutting edge technology!”
About Apostle Inc
Apostle Inc is a biotechnology company in Sunnyvale, CA. It’s in the business of the research, development, licensing, and sales of novel technologies, and the related intellectual properties, products, and services for diagnosis and treatment of human diseases, to fundamentally improve the accuracy and efficiency of liquid biopsy - the testing of circulating free DNA (cfDNA) - in early cancer detection or other clinical applications such as noninvasive prenatal testing (NIPT).
Apostle’s patent-pending technologies have 3 layers:
• Nanochemistry - Apostle MiniMax enables the capture and separation of circulating genetic material at a revolutionary 2X-10X higher efficiency over the conventional technologies;
• Bioinformatics - Apostle Triton AI learns from a cancer genomic big data of 30,000 patients;
• Hybrid - Apostle AID is a combination of MiniMax and Triton AI.
More information can be found at www.apostlebio.com.
About Filgen Inc
Filgen is a Japan based company that supports the development of biotechnology and medical research. Besides our house brand scientific instruments, we also offer biotechnology analysis services as well as research reagents and bioinformatics software. Specifically, these services include LC-MS/MS(iTRAQ), next generation sequencing, DNA microarrays, real time PCR and numerous other advanced technologies.
For more information: www.filgen.jp